(Alliance News) - Non-binding bids for Bioenerys, Snam's biomethane subsidiary valued at approximately EUR500 million, are expected by early May, as reported by Il Sole 24 Ore on Friday.
The transaction, managed by advisors Rothschild and BNP Paribas, is driven by regulatory requirements mandating that Snam divest its production assets by June 2027.
Verdalia, a Goldman Sachs-backed vehicle, is currently seen as the frontrunner. It is reportedly moving in tandem with Ludoil, which is interested in the organic waste (FORSU) plants.
Edison is also monitoring the dossier, with a specific focus on the organic fraction. The list of potential suitors is extensive, including multi-utilities such as A2A, Veolia, and Plures, alongside international funds like Macquarie, Antin, and Plenium.
Bioenerys operates approximately 40 plants across the agricultural and environmental sectors, with a capacity of 40 MW and a production target of 150 million cubic meters per year.
The sale represents a pivotal step in the consolidation of a sector vital to decarbonization, attracting interest from both industrial giants and infrastructure investors.
By Michele Cirulli, Alliance News reporter
Comments and questions to redazione@alliancenews.com
Copyright 2026 Alliance News IS Italian Service Ltd. All rights reserved.
